A Study To Evaluate Methods To Evaluate Back Pain
21 de febrero de 2013 actualizado por: Wyeth is now a wholly owned subsidiary of Pfizer
A Pilot Study To Evaluate Various Methodologies For Assessing The Treatment Of Low Back Pain
The study is designed to assess methods used in clinical research.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
61
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
California
-
Loma Linda, California, Estados Unidos, 92350
- Pfizer Investigational Site
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 55 años (Adulto)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Lower back pain
- Male or female in generally good health, from 18 to 55 years of age (inclusive)
Exclusion Criteria:
- Pregnant or lactating
- Subject has evidence or history of radiculopathy, i.e. sciatica extending below the knee (numbness, tingling, or shooting pain), or other neurologic deficits (abnormal straight leg raise test, patellar reflexes, and/or bowel and bladder function);
- Subject has a history of previous back surgery;
- Subject has back pain resulting from traumatic injury involving physical evidence of bruising, swelling, or inflammation to the abdomen or low back area which occurred less than 48 hours prior to enrollment
- Has taken an investigational drug within the past 30 days prior to entering the study, or currently enrolled in another investigational study
- Is a member or relative of the study site staff, CRO or Sponsor organization directly involved with the study or had a household member or relative participate concurrently or previously in this study
- Has previously been enrolled in this study
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: 1
Heat device
|
8-Hour Heatwrap
Otros nombres:
|
|
Comparador falso: 2
Placebo arm
|
Inactive wrap worn for 8 hours
|
|
Comparador activo: 3
Marketed analgesic
|
2 x 200 mg ibuprofen tablets
|
|
Comparador de placebos: 4
(Oral) Placebo comparator
|
2 x placebo tablets
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time to First Perceptible Relief (Confirmed by Meaningful Relief)
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) up to 4 hours
|
"First perceptible relief" defined as the elapsed time from wrap application or oral treatment until the participant depressed the first stopwatch labeled "first perceptible relief" (any pain relieving effect), provided the participant also depressed the second stopwatch labeled "meaningful relief" (meaningful to participant) by the end of the scheduled in-patient evaluation (4 hours / 240 minutes).
If the confirmation was not achieved, the participant was censored at the time when the first stopwatch was depressed.
Confidence interval (CI) calculated using the method of Simon & Lee.
|
Baseline (time of wrap application or oral treatment administration) up to 4 hours
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time to Meaningful Relief
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) up to 4 hours
|
Time to "meaningful relief" defined as elapsed time from start of treatment until participant depressed the second stopwatch indicating "meaningful relief" (meaningful to participant).
Participant consider censored if participant did not depress the stopwatch by end of 4-hour in-patient evaluation, or became a treatment failure (rescue or discontinuation) during the time prior to depressing the second stopwatch.
Censoring was at time of dropout if participant withdrew for non-efficacy related reasons during the 4-hour in-patient portion of the study.
CI calculated using method of Simon & Lee.
|
Baseline (time of wrap application or oral treatment administration) up to 4 hours
|
|
Time Weighted Sum of Pain Relief From 0 Through 8 Hours (TOTPAR 0-8)
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
TOTPAR 0-8 sum of pain relief from 0 through 8 hours, weighted by the time duration between the current timepoint and the previous timepoint.
Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief.
Total possible score 0 to 40; higher score indicated better relief.
|
Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
|
Time Weighted Sum of Change From Baseline in the Back Stiffness Score Over 8 Hours
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
Time weighted sum of change calculated as sum of change from baseline in back stiffness scores from 0 through 8 hours, weighted by time duration between current timepoint and previous timepoint.
Based on hourly (from baseline) back stiffness assessment rating from 0 (no muscle stiffness) to 100 (most possible muscle stiffness).
Sum of change derived by subtracting score at post-dosing time point from baseline score.
Total possible score -800 to 800; higher positive value was indicative of greater improvement.
|
Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
|
Time to Treatment Failure
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
Time to treatment failure defined as time from dosing to the time of rescue medication within the scheduled duration of the study (8 hours); or for participants who withdrew from the study due to lack of efficacy without taking rescue medication, the time of the last assessment was considered the time to treatment failure; or if participant did not take rescue medication, or did not discontinue due to lack of efficacy, the time to treatment failure was considered censored at 8 hours (the scheduled duration of the study).
|
Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
|
Individual Time-Point Pain Relief Scores
Periodo de tiempo: At 60, 120, 180, 240, 300, 360, 420, and 480 minutes
|
Pain relief rated hourly (from baseline) by the participant on a 6-point scale: 0=no relief, 1=a little relief, 2=less than half relief, 3=more than half relief, 4=a lot of relief, 5=complete relief.
|
At 60, 120, 180, 240, 300, 360, 420, and 480 minutes
|
|
Change From Baseline in Individual Time-point Back Stiffness Scores
Periodo de tiempo: At 60, 120, 180, 240, 300, 360, 420, and 480 minutes
|
Low back muscle stiffness rated hourly (from baseline) by the participant by placing a line on a visual analog scale (VAS) from 0 millimeters (mm) to 100 mm in length with 0=no muscle stiffness up to 100 (most possible stiffness).
|
At 60, 120, 180, 240, 300, 360, 420, and 480 minutes
|
|
Change From Baseline (Bsl) in Combined Flexibility Score: Extension
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Flexibility assessed using Paris Plinth table with maximum extension (as if performing a sit-up) of 20 degrees movement.
Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees minus 5, and x degrees plus 5. Flexibility score derived using standardized value and VAS score (participant rating of pain by marking level of pain on 100 mm line 0=no pain up to 100=worst pain).
Final derived data for extension flexibility were average of the extension flexibility data on the combined score (range -66 to 552); higher value indicated greater improvement.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline (Bsl) in Overall Combined Flexibility Score: Side-to-Side
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Flexibility assessed using Paris Plinth table with maximum side-to-side movement of plus or minus (+/-) 10 degrees for left, and right (L, R), movement.
Angle at Bsl and 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain to 100=worst pain).
Final derived data for overall flexibility was the average of side-to-side (L, R) flexibility data on the combined score (range -81 to 264); higher value=greater improvement.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline (Bsl) in Overall Combined Flexibility Score: Rotation
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Flexibility assessed using Paris Plinth table with maximum rotation at waist of plus or minus (+/-) 30 degrees for left, and right (L, R), movement.
Angle at Bsl and at 4 hours standardized to 100 for assessment of maximum angle (x degrees), x degrees - 5, and x degrees + 5. Flexibility score derived using standardized value and VAS score (participant rating of level of pain on 100 mm line 0=no pain up to 100=worst pain).
Final derived data for overall flexibility were the average of rotation (L, R) flexibility data on combined score (range -80 to 155); higher value=greater improvement.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Extension
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement of 20 degrees for extension (as if performing a sit-up) to the degree of movement at which participant perceives discomfort or pain.
Higher score indicated greater improvement.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Side-to-Side
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum movement +/- 10 degrees for left, and right, side-to-side movement to the degree of movement at which participant perceives discomfort or pain.
Maximum flexion based on the average of the left and right side-to-side scores.
Higher score indicated greater improvement.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline in the Angle Measurement at Maximum Flexion for Flexibility Measures: Rotation
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Participant placed in a prone position on Paris Plinth table which is moved at 1 degree per second to maximum rotation at waist of +/- 30 degrees for left, and right, movement to the degree of movement at which participant perceives discomfort or pain.
Maximum flexion based on the average of the left and right rotation scores.
Higher score indicated greater improvement.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline (Bsl) in Pain Measurement for Flexibility Measure: Extension
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Flexibility assessed using Paris Plinth table with maximum extension of 20 degrees movement (as if performing a sit-up).
When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain.
Movement decreased 5 degrees (minus) and discomfort rated on VAS.
Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS.
Higher score indicated greater discomfort/pain.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline in Pain Measurement for Flexibility Measure: Side-to-Side
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Flexibility assessed using Paris Plinth table with maximum side-to-side movement of +/- 10 degrees for L, R movement.
When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain.
Movement decreased 5 degrees (minus) and discomfort rated on VAS.
Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS.
Analyses based on the average of L, R scores.
Higher score indicated greater discomfort/pain.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Change From Baseline in Pain Measurement for Flexibility Measure: Rotation
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) and 4 hours
|
Flexibility assessed using Paris Plinth table with maximum rotation at waist of +/- 30 degrees for L, R movement.
When participant feels discomfort or pain, participant places a mark to rate discomfort/pain (maximum) on a VAS of 100 mm in length with 0=no discomfort/no pain up to 100=most discomfort/most pain.
Movement decreased 5 degrees (minus) and discomfort rated on VAS.
Movement increased 5 degrees (plus) beyond first point when pain was reported and discomfort/pain again rated on the VAS.
Analyses based on the average of L, R scores.
Higher score indicated greater discomfort/pain.
|
Baseline (time of wrap application or oral treatment administration) and 4 hours
|
|
Number of Participants Per Categorical Score for Global Assessment of Study Treatment
Periodo de tiempo: Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
At hour 8, or at the time of rescue, if it occurred, participants performed a global assessment in their diary in response to the question: How would you rate the study treatment as a pain reliever?
Very Poor=0, Poor=1, Fair=2, Good=3, Very Good=4, Excellent=5.
|
Baseline (time of wrap application or oral treatment administration) up to 8 hours
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de febrero de 2010
Finalización primaria (Actual)
1 de julio de 2010
Finalización del estudio (Actual)
1 de julio de 2010
Fechas de registro del estudio
Enviado por primera vez
8 de enero de 2010
Primero enviado que cumplió con los criterios de control de calidad
8 de enero de 2010
Publicado por primera vez (Estimar)
11 de enero de 2010
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
1 de abril de 2013
Última actualización enviada que cumplió con los criterios de control de calidad
21 de febrero de 2013
Última verificación
1 de febrero de 2013
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- TC-09-20
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Heat Device
-
Boston Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminadoObesidad infantil | Intervención de Obesidad Basada en TecnologíaEstados Unidos
-
Sunnybrook Health Sciences CentreAún no reclutandoLesiones Traumáticas | Hipotermia | Hemorragia masiva
-
University of California, DavisThrasher Research Fund; California Department of Health Services; University Research...Terminado
-
University of Illinois at Urbana-ChampaignTerminado
-
University Hospital, ToulouseTerminado
-
University of RochesterNational Cancer Institute (NCI)Aún no reclutandoCáncer de mama | Fatiga relacionada con el cáncerEstados Unidos
-
The University of Hong KongReclutamientoRecién nacido; hipertermiaPorcelana
-
The Cleveland ClinicTerminado